Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis.
Tso S, Satchwell F, Moiz H, Hari T, Dhariwal S, Barlow R, Forbat E, Randeva H, Tan YT, Ilchyshyn A, Kwok MM, Barber TM, Thind C, Tso ACY.
Clin Exp Dermatol. 2021 Aug;46(6):1001-1010. doi: 10.1111/ced.14625. Epub 2021 May 1.
The rash that becomes an erythroderma.
Inamadar AC, Ragunatha S.
Clin Dermatol. 2019 Mar-Apr;37(2):88-98. doi: 10.1016/j.clindermatol.2018.12.002. Epub 2018 Dec 5.
Erythroderma.
Rothe MJ, Bialy TL, Grant-Kels JM.
Dermatol Clin. 2000 Jul;18(3):405-15. doi: 10.1016/s0733-8635(05)70189-3.
Erythroderma in children.
Sarkar R, Garg VK.
Indian J Dermatol Venereol Leprol. 2010 Jul-Aug;76(4):341-7. doi: 10.4103/0378-6323.66576.
Paraneoplastic erythroderma: an insight on the existing data.
Plachouri KM, Georgiou S.
Int J Dermatol. 2020 Dec;59(12):1429-1436. doi: 10.1111/ijd.14970. Epub 2020 Jun 18.
Neonatal erythroderma.
Fraitag S, Bodemer C.
Curr Opin Pediatr. 2010 Aug;22(4):438-44. doi: 10.1097/MOP.0b013e32833bc396.
Etodolac-induced erythroderma.
Seara V, Costa-Fernandes S, Duarte M, Maia L.
Dermatol Online J. 2021 Nov 15;27(11). doi: 10.5070/D3271156099.
Rapidly Progressive Erythroderma.
Moon S, Israeli A, Daze R.
Am Fam Physician. 2022 Jan 1;105(1):75-76.
Neonatal erythroderma.
Cotter CL, Rivers E, Salisbury J, Duarte Williamson E, Tewari A.
Clin Exp Dermatol. 2020 Jul;45(5):646-649. doi: 10.1111/ced.14206. Epub 2020 Mar 25.
Erythroderma (exfoliative dermatitis). Part 2: energy homeostasis and dietetic management strategies.
Tso S, Moiz H, Satchwell F, Hari T, Dhariwal S, Barlow R, Forbat E, Blee IC, Tan YT, Thind C, Ilchyshyn A, Randeva H, Kwok MM, Tso ACY, Barber TM.
Clin Exp Dermatol. 2021 Aug;46(6):1011-1015. doi: 10.1111/ced.14667. Epub 2021 May 6.
